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C57Bl/6 female mice were infected with an intrapulmonary dose of 2×5 × 104 BCG (Mycobacterium bovis 
Bacillus Calmette-Guerin). Lymphocyte populations in lung interstitium and lung-associated tracheal lymph 
nodes (LN) were examined at 1, 2, 4, 5, 6, 8 and 12 weeks after inf ction. BCG load in lungs peaked between  
4–6 weeks post-infection and declined to very low levels by the 12th week of infection. Lung leukocytes were 
obtained over the course of infection by enzyme digestion of lung tissue followed by centrifugation over Percoll 
discontinuous density gradients. By 4 to 6 weeks after infection, numbers of lung leukocytes had more than 
doubled but the proportions of lymphocytes (about 70%), macrophages (about 18%) and granulocytes (about 
12%) remained essentially unatered. Flow cytometric studies indicated: (i) the total number of CD3+ T cells in 
lungs increased by 3-fold relative to uninfected controls at 5 to 6 weeks post-infection, but the relative 
proportions of CD4 and CD8 cells within the T cell compartment remined unaltered; (ii) relative proportion of 
NK cells in lungs declined by 30% but the total number of NK cells (NK1×1+) per lung increased by about 50%, 
5–6 weeks post infection; (iii) tracheal LN underwent marked increase in size and cell recoveries (6–10-fold 
increase) beginning 4 weeks after infection. While both T and B cells contributed to the increase in cell 
recoveries from infected tracheal LNs, the T/B ratio declined significantly but CD4/CD8 ratio remained 
unaltered. In control mice, IFNg producing non-T cells outnumbered T cells producing IFNg. However, as the 
adaptive response to infection evolves, marked increase occur in the number of IFNg producing T cells, but not 
NK cells in the lungs. Thus, T cells are the primary cell type responsible for the adaptive IFNg response to 
pulmonary BCG infection. Few T cells in tracheal LN of BCG infected mice produce IFNg, suggesting that 
maturational changes associated with migration to the lungs or residence in the lungs enhance the capability of 
some T cells to produce this cytokine. 
[Saxena R K, Weissman D, Simpson J and Lewis D M 2002 Murine model of BCG lung infection: Dynamics of lymphocyte 
subpopulations in lung interstitium and tracheal lymph nodes; J . Biosci. 27 143–153] 
 
1. Introduction 
One third of all human beings are estimated to be infected 
with Mycobacterium tuberculosis, which makes tuber-
culosis one of the most serious global health problems. 
Three million people die of TB and 8 million fresh cases 
are detected each year (Bleed et al 2000). BCG (Myco- 
 
bacterium bovis Bacillus Calmette-Guerin) which is the 
only vaccine available against tuberculosis, has an 
efficacy ranging from 0% to 80% (Fine 1989; Orme 
1999). A proper understanding of immune response to M. 
tub rculosis will pave the way for developing more 
effective vaccines against tuberculosis. Immune response 
to M. tuberculosis n the mouse model has been studied  
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(Huygen et al 1992; Andersen 1997; Ibsen et al 1997). 
Systemic and lung infections with mycobacteria may 
induce qualitatively different types of immune responses. 
Mice were reported to be a hundred-fol  more susceptible 
to infection initiated in lungs than the infection initiated 
systemically (North 1995). The primary portal of entry of 
M. tuberculosis the lung. It is therefore important to 
understand the nature of immune responses to myco-
bacterial infection in lungs. BCG lung infection in mice 
resembles human infection in as much as the infection is 
effectively contained in both cases. Some information about 
the immune r sponse to BCG lung infection in mice is 
available (Wakeham et al 1998; Xing et al 1998; Fulton 
et al 2000). Infection peaks at 4 to 6 weeks after intra-
tracheal (IT) deposition of BCG and there is an associated
surge in T cells in the lung interstitium (Fulton et al 
2000). Broncho-alveolar lavage contains increased levels 
of cytokines associated with T-helper (Th)1-type responses 
such as IFNg, IL12 and TNFa (Wakeham et al 1998). 
Mouse models using immunodeficient and knockout mice 
have demonstrated a crucial role of type I cytokine res-
ponse, especially IFNg, in protective immunity to M. 
tuberculosis (Flynn et al 1993; North and Izzo 1993; 
Cooper et al 1993, 1997; Wakeham et al 1998). T cells as 
well as NK cells can produce IFNg. The kinetics of acti-
vation and accumulation of these cells in lungs of infected 
mice is not clearly understood. Moreover the relative 
contribution of these lymphocyte subsets to IFNg secre-
tion is not known. 
 The over-arching hypothesis for the current study is 
that Th1 responses, particularly IFNg responses, play a 
key role in clearance of mycobacterial infection from the 
lungs. Two types of lymphocytes i.e. T cells and NK 
cells can produce IFNg. While the crucial role of IFNg in 
protective immunity to mycobacterial infections has been 
demonstrated, relative contribution of T and NK cells to 
the local secretion of IFNg in lungs infected with myco-
bacteria is not known. In the present study, we have 
documented the kinetics of changes in various lymphocyte 
subpopulations after murine pulmonary BCG infection. 
Relative contribution of T and NK cells in producing 
IFNg has also been analysed. Our results show that both 
T and NK cells contribute to local IFNg production in 
control and BCG infected mouse lungs. In BCG infected 
mice however, the augmented IFNg response is essentially 
due to the expansion of IFNg producing T cell subsets. 
2. Materials and methods 
2.1 Mice 
C57Bl/6 female mice 12 to 15 weeks of age were obtain d 
from Jackson Laboratories, Bar Harbor, ME, USA and 
used between 18 and 30 weeks of age. Mice were 
maintained in filter- opped cages provided with HEPA-
filtered air in the animal facilities at NIOSH. All studies 
were reviewed and approved by the NIOSH Institutional 
Animal Care and Use Committee. 
 
2.2 Reagents 
Percoll, phorbol 12-myristate 13-acetate (PMA), iono-
mycin, collagenase (cat No. C5138), DNAse (cat. No. 
D4263), hyluronidase (cat No. H3506), elastase (cat No. 
E0258), goat- nti-mouse Ig-FITC (specific for Fab), and 
RPMI 1640 culture medium werebought from Sigma, St. 
Louis, MO, USA. Monoclonal antibodies (Mabs) labelled 
with FITC or PE [anti-CD3 (clone 17A2); anti-NK1×1 
(clone PK136); anti-CD4 (clone GK1×5); anti-CD8 (clone 
53-6×6); anti-CD16/32 (Fc-block, clone 2×4G2); anti-
mouse IFNg (clone XMG1×2)] and their respective iso-
typic controls were obtained from Pharmingen (Pharmingen/ 
Becton Dickinson, San Diego, CA, USA). Middlebrook 
culture medium and supplements were obtained from 
Becton Dickinson Microbiology Systems, Sparks, MD, 
USA. 
2.3 Intrapulmonary instillation of BCG 
A seed culture of BCG (M. bovis Pasteur, TMCC No. 
1011) was kindly provided by Prof. Ian Orme of the 
Microbiology Department, Colorado State University, 
F rt Collins, CO, USA. BCG was grown in Middle- 
brook culture medium with OADC supplement and 
Tween. Viable BCG were counted by plating bacterial 
susp nsions at different dilutions on Middlebrook agar 
plates and counting colonies after two weeks. Intra-
pulmonary instillation of BCG suspension (50 ml bacte- 
rial suspension containing 2×5 × 104 bacteria/mouse) or  
PBS was carried out as de cribed by Keane-Myers et al 
(1998). 
 
2.4 Tissue processing 
Mice were sacrificed by pentobarbital overdose. Spleen 
and liver were homogenized in 10 ml PBS using a 
Polytron homogenizer. Aliquots (100 ml) of neat or appro-
priately diluted homogenates were plated on Middlebrook 
Agar plates. BCG colonies were counted two weeks later. 
In order to minimize contamination of lung interstitial 
leukocyte preparations by blood derived cells, lungs were 
perfused with PBS via the right atrium before their 
removal. Isolation of lung interstitial cells was done by 
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enzymatic digestion of lung tissue, mechanical dispersion, 
and separation on a discontinuous Percoll gradient essen-
tially as described (Wakeham et al 1998). Briefly, lung 
tissue was chopped into small pieces (1–2 mm) and 
incubated in a solution containing collagenase (150 U/ml), 
DNAse (20 Kunitz/ml), hyaluronidase (35U/ml) and 
elastase (0×2 U/ml) in PBS, for 90 min on a rocking 
platform at 37°C. Digested lung tissue was grounded 
through a stainless steel mesh and the resulting suspension 
filtered through 100-micron filter to remove tissue debris. 
Leukocytes were isolated by discontinuous Percoll gradi-
ent centrifugation (Wakham et al 1998). Differential cell 
counts were performed using cytospin preparations stained 
with May-Grunwald-Giemsa. For each cell preparation, 
at least 200 cells were counted. The right tracheal lymph 
node (LN) known to receive drainage from the lung, was 
removed from the superior right side of the mediastinum 
cavity and teased in PBS to obtain cells. 
2.5 Flow cytometric analysis  
Cells derived from lungs and tracheal LN were stained 
with monoclonal antibodies against several membrane 
markers as well as against IFNg to detect cytoplasmic 
IFNg. Staining protocols suggested by the manufacturer 
(BD Pharmingen, San Diego, CA, USA) were followed. 
Cells were analysed on a Becton Dickinson FACS 
Calibur flow cytometer. Cells stained with isotypic control 
antibodies were used to demarcate the lymphocyte wind w 
as well as to set gates for discrimination between cells 
with or without specific stain. The gates would have 
included all types of lymphocytes. 
2.6 Serum anti-BCG antibody titers 
Anti-BCG antibody concentrations in mouse sera were 
determined by ELISA as described before (Udaykumar et 
al 1991). Briefly, ELISA plate wells were coated with 
BCG sonicate antigen (1 mg in 50 ml/well in 0×2 M bicar-
bonate buffer, pH 9×6, overnight at room temperature) 
and blocked with milk proteins (1×0% milk powder in 
PBS). Reactivity was studied with various diluted mouse 
sera (50 ml/well, overnight incubation at 4°C). Bound 
antibody was detected using a goat anti-mouse-Ig-alkaline 
phosphatase detecting antibody followed by the chromo-
genic substrate p-nitrophenyl phosphate. Relative anti-
body concentrations are expressed as colour developm nt 
measured as absorbence at 405 nm. 
2.7 Statistical analysis 
Unless specified otherwise, data from at least five con- 
trol and 5 BCG infected mice were compared at diffe- 
rent time points in all experiments. Each experiment was 
repeated at least three times with reproducible results. 
Representative data from each experiment has been 
hown. Two-way comparisons were performed using 
Stud t’s t-test. Multiple comparisons were performed by 
analysis of varince and an appropriate multiple com-
parison procedure. Comparisons were made using computer 
software (Sigmast t, SPSS, Chicago, IL, USA). Com-
parisons were considered significantly different at a level 
of P £ 0×05. 
3. Results 
At least three experiments were done to confirm each 
result. Only representative data have been shown, based on 
an experiment utilizing 70 mice. Ten mice (5 control and 5 
infected mice) were sacrificed at each of the seven time 
points shown. Representative data for antibody titres in sera 
samples from four infected mice at different times after the 
initiation of the lung infection, are shown in figure 7. 
3.1 Course of BCG infection in C57Bl/6 mice 
Results in figure 1 show BCG counts in lung, spleen and 
liver of BCG-instilled mice at various time points after  
 
 
 
Figure 1. Bacterial load in lungs, spleens and livers of 
C57Bl/6 with intrapulmonary instillation of BCG. BCG was 
instilled in lungs of C57Bl/6 female mice (2×5 × 104 bacteria in 
50 ml PBS to each mouse). At various given time periods after 
the initiation of the infection, BCG load in lungs, spleens and 
livers from infected mice was determined as described in §2. 
Bacterial loads in spleen and liver after one week of infection 
were too low to be included. Each value represents a mean 
± SD of five observations. 
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infection. One week after infection, BCG recovery from 
lungs averaged 10% of the instilled inocula. BCG oad  
in lungs increased and peaked between 4 to 6 weeks,  
after which it declined. Highest average bacterial load 
(4×3 × 104/lung) was attained six weeks after infection.  
By the 12th week after infection, BCG were essentially 
cleared from lungs. Parallel ssessment of BCG load in 
spleen indicates that one week after infection, spleens 
were devoid of any bacterial load. Few BCG colonies 
could be detected in spleens two weeks after infection, 
and the bacterial load further increased till 6th week, 
after which it appeared to plateau. Significant metastasis 
of BCG to liver was not observed, as the average BCG 
load remained below 100 colonies per liver at all time  
points. 
3.2 Effect of BCG lung infection on the recovery of lung 
interstitial leukocytes 
Interstitial lung leukocytes were obtained by enzyme 
digestion of lung tissue followed by discontinuous Percoll 
gradient centrifugation. Using this technique, average 
leukocyte recovery in control groups of mice varied 
betw en 1×2 and 3×0 × 106/lung at different time points 
(figure 2). At each time point the recovery of lung inter-
stitial leukocytes from BCG instilled mice was compared 
to th  corresponding recoveries from PBS instilled control 
mice. Results in figure 2 indicate that leukocyte recovery 
from lungs of infected mice was significantly greater than 
the control recoveries at 5, 6, and 8 weeks after infection 
(figure 2, lower panel). Maximum increases of about  
 
 
Figure 2. Time kinetics of leukocyte recoveries from lungs of control (PBS instilled) and infected 
(BCG instilled) C57Bl/6 mice. Y axis scale on the left corresponds to the histograms in the lower part of 
the figure and the Y axis scale on the right is for the curve shown in the upper part of the figure. Each 
value of cell recovery is a mean± SD of five observations. *BCG group different from control group, 
unpaired t-test, P < 0×05. 
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100% were seen on the 5th and 6th weeks post-infection 
(figure 2, upper panel). Differential leukocyte count was 
done on cell preparations derived from lungs. Typically, 
lymphocytes, macrophages and granulocytes comprised 
70×7 ± 8×2%, 16×6 ± 8×8% and 12×7 ± 4×4% respectively 
of the total lung leukocytes derived from control mice 
(dotted lines in figure 3). The proportions of lymphocytes, 
macrophages and granulocytes in lungs of mice infected 
with BCG at different intervals after infection are shown 
i  figure 3. In general, no large fluctuations were noted in 
the relative proportions of lymphocytes, macrophages, 
and granulocytes over the course of BCG infection. 
However, a statistically significant (P < 0×05) increase in 
the proportions of neutrophils, macrophages and lympho-
cytes relative to control was observed at the 1st, 2nd and 
6th week points respectively (figure 3). 
 
 
Figure 3. Proportions of lymphocytes, macrophages and granulocytes in leukocyte 
preparations derived from lungs of control (PBS instilled) and infected (BCG instilled) 
mice. Values of differential counts represent mean ± SD of 5 observations. Horizontal 
dotted lines represent mean of 30 observations in non-infected control group. *Difference 
of BCG group from control group by Dunnett’s multiple comparison test, P < 0×05. 
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3.3 Phenotypic make up of lymphocytes derived from 
lungs of control and BCG infected mice 
Flow cytometric analysis was used to enumerate lympho-
cyte subpopulations in lungs at each time point. In all 
phenotypic studies, a lymphocyte gate was set on the 
forward/side scatter plot. Cells were stained and analysed 
for the expression of CD3, CD4, CD8, NK1×1, gd TCR 
and surface Ig markers. T cells (CD3+) as percentage of 
all lung lymphocytes from BCG or PBS (control) 
instilled mice, are shown in the bottom panel of figure 4. 
These results indicate that the absolute numbers of T cell 
proportions increased significantly in BCG infected mice 
especially at the 5th week time point, when the increase 
in T cell proportion was about 50% (top panel, figure 4). 
Similar data for NK cell proportions are given in figure 5. 
Proportions of NK cells declined by 30% relative to 
control (P < 0×05) at the 4th, 5th and 6th week points, 
which corresponded with an increase in relative propor-
tion of T cells at these time points. T cells thus increased 
and NK cell decreased in BCG infected lungs in terms of 
percentages of all lung lymphocytes. Figure 2 however 
shows that the total lung cell recovery doubled in BCG 
infected lungs at the peak of infection. Knowing the total 
cell recoveries and the proportion of T and NK cells, 
absolute numbers of T and NK cells in control and BCG 
infected lungs could be computed. Absolute numbers of 
both T and NK cells increased in BCG infected lungs, 
though the increase was much larger for T cells (about 3-
fold) than for NK cells (about 50% increase). 
 Proportions of CD4+ and CD8+ T cells were also 
determined in lung cells from control and BCG infected 
mice 5, 6, and 8 weeks post infection. The average 
CD4/CD8 ratio in lungs of control mice was 1×2 ± 0×2  
(mean ± SD of 20 determinations, range 0×97 to 1×90). 
This ratio was not significantly altered at any time point 
in BCG infected mice and was 1×22 ± 0×08, 1×22 ± 0×13 
and 1×27 ± 0×03 respectively at 5, 6 and 8 weeks post infec-
tion. Relative proportions of gd T cells in lung-derived 
lym hocytes was < 2% and remained unaltered in BCG 
infected mice examined 5 weeks post infection (results 
not shown). Proportion of surface Ig+ B cells in lung 
 
 
Figure 4. Time kinetics of changes in proportions of CD3+ lymphocytes in lungs of control (PBS instilled) and infected (BCG 
instilled) mice. Lower panel (Y axis scale on the left) denotes the percentage of CD3+ cells in lung cell preparations from control 
and BCG infected mice. Upper panel (Y axis scale on the right) shows the percent change in the proportions of T cells in lungs of 
BCG infected mice. All values in lower panel represent mean ± SD of 5 observations. 
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lymphocytes in control and BCG infected mice (6 week 
point) were 44×  ± 2×36% and 45×1 ± 1×97% respectively, 
indicating that the relative proportions of B cells were 
not changed in the lungs of BCG infected mice. 
3.4 Lymphocyte subpopulations in tracheal LN from 
control and BCG infected mice
Recoveries of cells from tracheal LN in control and BCG 
infected mice are shown in table 1. Average lymphocyte 
recoveries from tracheal LN of uninfected mice was 
1×29 ± 0×54 × 106 which increased by 6- to 12-fold in 
BCG infected mice (table 1). Both T and B cells contri-
buted to increased cell recovery, though the increase in B 
cell numbers (>12-fold) was relatively greater than the 
increase in T cells (7-fold). NK cells and g  T cells com-
prised less than 1% of lymph node cells and no significant 
change in the proportion of these cells occurred in BCG 
infected mice (results not shown). 
3.5 IFNg production by lung and tracheal LN  
cells at the peak of BCG infection 
Both T and NK cells have the capacity to secrete IFNg. 
We examined the proportion of T cells in lung interstitium 
and tracheal lymph nodes, producing IFNg at the peak of 
BCG infection. Results of a representative experiment of 
two colour flow cytometry with intercellular ytoplasmic 
staining for IFNg and surface staining for CD3 marker, 
are given in figure 6 (upper panel). These results show 
that 11×67% of the total lymphocytes in lung interstitium 
were T cells with intercellular IFNg whereas this percentage 
was 2×44% for control lungs. There was thus a marked 
increase (4–5-fold) in T cells making IFNg in BCG 
infected lungs. In contrast to lung cells from control and 
BCG infected mice, tracheal LN cells from control as 
well as BCG infected mice had few IFNg producing cells 
(figure 6, bottom panel). The proportion of tracheal LN 
cells, which stained for cytoplasmic IFNg in all such 
experiments remained less than 1%. 
 Significant numbers (4×8% of lung lymphocytes) of 
non-T cells (CD3 negative) produced IFNg in control 
lungs, and this percentage remained unchanged in BCG 
infected lungs (figure 6, upper panel). Non-T cells (CD3–) 
 
Figure 5. Time kinetics of changes in proportions of NK1× +
lymphocytes in lungs of control (PBS instilled) and infected 
(BCG instilled) mice. Lower panel (Y axis scale on the left) 
denotes the percentage of NK1×1+ cells in lung cell preparations 
from control and BCG infected mice. Upper panel (Y axis scale 
on the right) shows the percent change in the proportions of NK 
cells in lungs of BCG infected mice. All values in lower panel 
represent mean ± SD of 5 observations. 
 
Table 1. Cell recoveries from lung associated tracheal lymph nodes from control and BCG infected mice.       
  Cells/lymph node (× 106) 
Treatment  
group 
Duration of 
infection 
 
Total 
 
CD3+ 
 
CD4+ 
 
CD8+ 
 
sIg+               
Control None 1×29 ± 0×54 0×64 ± 0×24 0×33 ± 0×12 0×30 ± 0×13 0×57 ± 0×29 
BCG infected  4 weeks  8×72 ± 4×15* 3×39 ± 1×66* ND ND 4×65 ± 2×26* 
BCG infected  8 weeks 12×82 ± 6×46* 4×63 ± 1×73* 2×31 ± 0×78* 2×31 ± 0×83* 6×80 ± 4×05* 
BCG infected 12 weeks 12×02 ± 8×02* 4×38 ± 3×07* 2×21 ± 1×48* 2×17 ± 0×59* 7×11 ± 4×75*               
Lymph node cells were obtained from control (PBS instilled) and infected (BCG instilled) mice and analysed for various surface 
markers. Each value is a mean ± SD of 5 to 7 observations. Statistical difference betwen con rol and infected groups were assessed 
by analysis of variance and Dunnett’s multiple variance procedure (*P < 0×05). 
ND, Not determined. 
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with cytoplasmic IFNg are likely to be NK cells. To 
confirm this, we stained lung lymphocytes derived from 
5 week BCG infected mice with two combinations of 
antibodies, (i) membrane staining with anti-NK1×1 and 
cytoplasmic staining for IFNg, and (ii) membrane staining 
with anti-CD3 and cytoplasmic staining for IFNg. Results 
of 5 such experiments summarized in table 2 show that 
the percentages of NK cells making IFNg closely matched 
the percentages of CD3– cells making IFNg. Similarly, 
percentages of CD3+ cells making IFNg and NK1×1– cells 
making IFNg closely matched. The ratio of CD3+ IFNg+ 
and CD3– IFNg+ producing cells was 2×18, which was the 
same for NK1×1– IFNg+ and NK1×1+ IFNg+. These results 
strongly suggest that both NK and T cells contribute to 
IFNg production in the lungs of BCG infected mice and 
that CD3– IFNg+ cells represent NK cells producing IFNg. 
3.6 Antibody response in BCG infected mice 
At each time point after IT instillation of BCG, sera were 
collected to study the generation of circulating anti-BCG 
antibodies. Colour development in the anti-BCG antibody 
ELISA was determined using sera diluted to 1 : 10, 1 : 30 
and 1 : 90 (figure 7). Results clearly indicate a lack of 
substantial antibody response extending until 8 weeks 
after infection. A significant increase in serum anti-BCG
antibody levels were however noted in sera obtained 12 
weeks after the initiation of the BCG infection (P < 0×05). 
4. Discussion 
Cellular basis of lung immunity against BCG infection in 
mouse lungs is beginning to be understood (Wakeham  
et al 1998; Xing et al 1998; Fulton et al 2000). An 
increase in T cells in lung interstitium and elevated Th1 
cytokines like IFNg, TNFa and IL12 in broncho-alveolar 
lavage have been demonstrated (Wakeham et al 1998). 
 
 
Figure 6. Flow cytometric assessment of cells with cyto-
plasmic IFNg in lungs and tracheal LNs of control and BCG 
infected mice. Lung cells (A and B) and tracheal LNs (C and 
D) were derived from mice instilled with PBS (A and C) or 
BCG (B and D) six weeks before sacrifice. Cells were double 
stained with anti-CD3-FITC and anti-IFNg-PE. Values in diffe-
rent quadrants denote the percentage of cells in those quadrant . 
 
A B 
C D 
Table 2. Comparison of IFNg producing lymphocytes in BCG infected mouse lungs: CD3+ 
IFNg+ cells with NK1× – IFNg+ and NK1×1+ IFNg+ cells with CD3– IFNg+ cells*.     
 Lung derived lymphocytes with described phenotype (%) 
 
 
Lung cell 
Stain NK1×1 vs IFNg Stain CD3 vs IFNg 
 
preparation NK1×1+ IFNg+ NK1×1– IFNg+ CD3+ IFNg+ CD3– IFNg+           
1 2×40 5×90 5×30 2×23 
2 2×15 7×08 6×12 2×90 
3 2×73 6×01 5×25 2×70 
4 2×36 5×25 4×58 2×99 
5 1×87 4×52 3×78 2×38 
Mean ± SD 2×30 ± 0×32 5×01 ± 0×88 5×75 ± 0×95 2×64 ± 0×33           
*Five lung derived leukocyte preparations derived from mice intratracheally infected with 
BCG for 5 weeks, were double stained with (i) NK1×1 and IFNg antibodies, and (ii) CD3 
and IFNg antibodies. NK1×1 and CD3 antibodies were used for surface taining and IFNg 
antibody for cytoplasmic stain after fixing/permabilization of cells. Percent NK1×1+ and 
NK1×1– cells making IFNg and percent CD3+ cells and CD3– cells making IFNg for each 
cell preparation was estimated by flow cytometric analysis as described in §2. 
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While IFNg plays a key role in inducing anti-myco-
bacterial immunity (Cooper et al 1993; Flynn et al 1993), 
the identity of cells which secrete IFNg, their relative 
proportions, and the kinetics of their accumulation in 
lungs have not been established. In the present study, our 
primary aim was to delineate the kinetics of accumulation 
of different lymphocyte subsets in the lungs of BCG 
infected mice and to identify cells containing IFNg in 
their cytoplasm, as these cells are expected to secrete the 
cytokine. 
 The pattern of changes observed in bacterial load in 
lungs and other tissues following IT installation of a 
small number of BCG (2×5 × 104/mouse) was similar to 
that reported by others (Wakeham et al 1998; Fulton et al 
2000). Peak bacterial load in lungs was attained between 
4 to 6 weeks and it declined to very low levels by the 
12th week of infection. These results would suggest that 
protective immune responses in lungs become effective 
from the 4th week onwards. The bacterial load in the 
spleen, which must have been acquired after dissemina-
tion of infection via the circulation, increased until the 
6th week and persisted at high levels on the 12th week 
after infection. Sustained infection in the spleen, after the 
infection has been cleared from the lungs suggests that 
either the systemic protective responses may take more 
time to develop than local protective responses after IT 
instillation of BCG, or that the spleen is a favoured site 
for growth of BCG. 
 Timing of initiation of protective immunity in lungs is 
also suggested by the kinetics of leukocyte influx into the 
lungs. By the 5th and 6th week after infection, recovery 
of leukocytes from BCG-infected lungs was double as 
compared to control lungs. Interestingly, in spite of 
doubling of total leukocyte recovery from infected lungs, 
the relative proportions of granulocytes, lymphocytes and 
macrophages essentially remained unchanged. A marginal 
increase in granulocyte proportion on day 1 and of 
acrophages later on day 2, could reflect the sequence of 
events observed in most inflammatory reactions (Larsen 
and Henson 1983). Almost 70% of the leukocytes were 
lymphocytes. Since lymphocytes are involved in imparting 
adaptive immunity, we made a detailed analysis of 
lymphocyte subpopulations present in lungs of control 
and BCG infected mice. Our results indicate that the lung 
interstitium accumulates relatively high levels of NK 
cells (range 14–28% of lung lymphocytes), as compared 
to some lymphoid tissues lik spleen (NK cells < 5%), 
(Reic linet al 1999). These results corroborate the 
previously reported higher levels of NK activity in mouse 
lungs (Wiltrout et al 1985). Our results also show that a 
subset of NK cells from control lungs appear to make 
IFNg (figure 6), which could either be spontaneous or a 
consequence of exposure to environmental antigens. It is 
possible that the purpose of high accumulation of NK 
cells in lung interstitium is to secrete and maintain a 
certain basal level of IFNg in order to afford a protection 
from vi al and other infectious agents commonly encoun-
tered in lungs. NK cells are known to play an important 
role in natural immunity (Trinchieri 1995), and our 
results support a similar role for NK cells in lungs.
 Proportions of T cells increased in BCG infected mice, 
o  exp nse of NK cells whose proportions declined. In 
terms of absolute numbers however, both T as well NK 
cells increased in the lungs of BCG infected mice; 
 
Figure 7. Serum anti-BCG antibody levels after murine pulmonary BCG infection. Anti-BCG antibody levels were determined by 
ELISA and are expressed as ELISA absorbence at 405 nm. Each panel represents a different time point after infection, and different 
curves in each panel represent sera from individual animals. 
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increase in T cells being much higher than that in NK 
cells. Since greater proportions of T cells make IFNg in 
lungs of BCG infected mice, relative enrichment of T 
cells may be a beneficial response aimed at augmenting 
the secretion of protective IFNg locally at the site of 
infection. Significant numbers of non-T lymphocytes made 
IFNg in control as well as BCG infected lungs. Since 
non-T cells making IFNg were essentially NK cells, these 
results indicate that besides T cells, NK cells may also 
contribute significantly to the overall IFNg response in 
lungs of control and BCG infected mice. 
 A marked increase in the size of lung associated lymph 
nodes (tracheal LN) was observed in BCG infected mice. 
Interestingly while the numbers of both T and B cells 
increased in infected tracheal LNs, the extent of increase 
was greater for B cells. Mean T/B ratio in tracheal LNs 
fell progressively from 1×12 in control mice to about 
0×61, 12 weeks after BCG infection. It is possible that the 
relative lower proportions of T cells in tracheal LNs of 
infected mice was due to migration of activated T cells to 
lungs and other mucosal sites or to a greater inherent 
proliferative response of B cells, or both. Interestingly, in 
contrast to lung cells, few IFNg secreting cells (< 0×5%) 
could be demonstrated in tracheal LNs otherwise under-
going massive expansion in response to BCG challenge. 
Lack of IFNg production in T cells derived from tracheal 
LNs and an increased IFNg secretory response in T cells 
derived from lungs suggests the occurrence of matura-
tional changes associated with migration to, or residence 
in the lungs. In this regard, it is well known that intra-
pulmonary T cells are mostly mature (memory) T cells, 
while a large proportion of circulating T cells are naive 
(Agostini et al 1993). Cytokine networking with a number
of pulmonary cell types, including endoth lial cells, 
fibroblasts, epithelial cells, and macrophages, might 
account for the development of IFNg positivity in mature 
pulmonary effector T cells. 
 Significant anti-BCG antibody titers were detected in 
the sera of BCG infected mice 12 weeks after the 
initiation of infection. These findings are consistent with 
serologic responses in human TB, where serum anti-TB 
antibodies do not always increase during latent TB infec-
tion but are frequently increased during active disease 
(Udaykumar et al 1991). As the clearance of BCG 
infection from the lungs occurred prior to the develop-
ment of a substantial antibody response, our results do 
not suggest an important role for humoral immune res-
ponses in pulmonary host defense against this infection.
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